
Soliton, Inc. SOLY
Soliton, Inc. General and Administrative Expenses 2011-2026 | SOLY
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Soliton, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 8.46 M | 7.43 M | 3.11 M | 3 M | 3.05 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.46 M | 3 M | 5.01 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Globus Medical
GMED
|
1.18 B | $ 90.0 | 1.58 % | $ 12.2 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
382 M | $ 11.94 | -1.08 % | $ 1.61 B | ||
|
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | ||
|
Helius Medical Technologies
HSDT
|
9.27 M | $ 1.83 | -3.68 % | $ 1.11 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
717 M | $ 9.33 | 0.21 % | $ 719 M | ||
|
ClearPoint Neuro
CLPT
|
16.5 M | $ 9.07 | -3.3 % | $ 257 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
894 M | $ 36.67 | -0.19 % | $ 5.46 K | ||
|
IRIDEX Corporation
IRIX
|
7.73 M | $ 1.03 | 3.35 % | $ 17.4 M | ||
|
Integer Holdings Corporation
ITGR
|
212 M | $ 85.11 | -0.61 % | $ 2.96 B | ||
|
OrthoPediatrics Corp.
KIDS
|
120 M | $ 15.76 | -1.13 % | $ 370 M | ||
|
LENSAR
LNSR
|
45.2 M | $ 5.63 | -4.41 % | $ 67.3 M | ||
|
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | ||
|
Medtronic PLC
MDT
|
10.8 B | $ 86.42 | 0.15 % | $ 111 B | ||
|
FONAR Corporation
FONR
|
23.5 M | $ 18.58 | -0.11 % | $ 122 M | ||
|
Myomo
MYO
|
14 M | $ 0.68 | -3.62 % | $ 28.5 M | ||
|
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.4 | -1.73 % | $ 127 M | ||
|
Orthofix Medical
OFIX
|
554 M | $ 11.71 | -0.51 % | $ 464 M | ||
|
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
1.76 B | $ 166.87 | -2.91 % | $ 12.5 B | ||
|
AxoGen
AXGN
|
44.6 M | $ 30.99 | -5.06 % | $ 1.43 B | ||
|
Insulet Corporation
PODD
|
1.16 B | $ 202.46 | -0.51 % | $ 14.2 B | ||
|
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M | ||
|
Sintx Technologies
SINT
|
6.2 M | $ 2.66 | 5.14 % | $ 7.38 M | ||
|
Smith & Nephew plc
SNN
|
2.72 B | $ 31.73 | -2.74 % | $ 23.8 B | ||
|
Stryker Corporation
SYK
|
8.65 B | $ 332.07 | -0.1 % | $ 127 B | ||
|
Tactile Systems Technology
TCMD
|
88.7 M | $ 24.05 | -2.12 % | $ 550 M | ||
|
Butterfly Network
BFLY
|
39.8 M | $ 4.05 | -1.94 % | $ 857 M | ||
|
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | ||
|
Tandem Diabetes Care
TNDM
|
445 M | $ 18.28 | -4.64 % | $ 1.24 B | ||
|
Cytosorbents Corporation
CTSO
|
35.6 M | $ 0.61 | 3.37 % | $ 38 M | ||
|
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
43.5 M | $ 9.67 | -0.31 % | $ 346 M | ||
|
BioSig Technologies
BSGM
|
67.5 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
6.89 B | $ 61.86 | -1.17 % | $ 91.6 B | ||
|
Alphatec Holdings
ATEC
|
499 M | $ 11.03 | 0.55 % | $ 1.66 B | ||
|
Varex Imaging Corporation
VREX
|
133 M | $ 10.59 | 0.28 % | $ 438 M | ||
|
CONMED Corporation
CNMD
|
132 M | $ 34.54 | 1.35 % | $ 1.07 B | ||
|
Beyond Air
XAIR
|
26 M | $ 0.71 | 0.14 % | $ 48.1 M |